FDA
-
-
-
-
-
-
-
Silo Pharma Announces Strategic Business Expansion into Multi-Billion Dollar AI Agent Market with Acquisition of Managed AI Agent Platform, Qwikagents
-
-
-
-
-
-
-
Silo Pharma receives Japanese patent for licensed PTSD drug SPC-15
-
-
-
-
-
-
-
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
-
-
-
-
-
-
-
Silo Pharma (SILO) Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
-
-
-
-
-
-
-
Silo Pharma’s SP-26 Ketamine Implant Meets All Endpoints in Fibromyalgia Study
-
-
-
-
-
-
-
Silo Pharma Expands Intellectual Property Portfolio with Provisional Patent Filing for Innovative SPC-15 Combination Treatment
-
-
-
-
-
-
-
Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial
-
322,748 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

